For Providers

This non-invasive, at-home urine-based cancer screening solution is designed to reduce barriers to early detection among populations reluctant to seek traditional care. Notably, a significant proportion of men reporting hematuria delay or avoid medical consultation, contributing to late-stage bladder cancer diagnoses. By offering a convenient and accessible screening alternative, this approach aims to improve patient compliance, support earlier clinical intervention, and enhance population-level screening coverage for bladder, prostate, and cervical cancers. The solution may serve as a complementary tool to existing screening pathways, particularly for underserved or avoidance-prone patient groups.